The genetic and biologic aspects of treatment response and resistance in male germ cell cancer.
Kurie
J M
JM
Department of Medicine, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New York, NY 10021.
Bosl
G J
GJ
Dmitrovsky
E
E
D002352:Carrier Proteins / Q000378:metabolism; D002471:Cell Transformation, Neoplastic; D002881:Chromosomes, Human, Pair 12; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004351:Drug Resistance / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D011905:Genes, ras; D005819:Genetic Markers; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D018168:Receptors, Retinoic Acid; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D014212:Tretinoin / Q000378:metabolism
D002352:Carrier Proteins; D005819:Genetic Markers; D018168:Receptors, Retinoic Acid; D014212:Tretinoin; D002945:Cisplatin